What is he best known for?
The fields of study he is best known for:
Androgen receptor, Internal medicine, Selective androgen receptor modulator, Pharmacology and Endocrinology are his primary areas of study.
His research in Androgen receptor intersects with topics in Testosterone, Androgen, Dihydrotestosterone and Agonist.
His study in the fields of Sarcopenia, Cachexia and Prostate cancer under the domain of Internal medicine overlaps with other disciplines such as Lean body mass.
His Selective androgen receptor modulator study combines topics in areas such as Osteoporosis and Skeletal muscle.
His Pharmacology research incorporates elements of Receptor, Androgen Therapy, In vivo and Prostate.
His study looks at the relationship between Endocrinology and fields such as Estrogen receptor, as well as how they intersect with chemical problems.
His most cited work include:
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros (832 citations)
- Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations (541 citations)
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma (363 citations)
What are the main themes of his work throughout his whole career to date?
James T. Dalton spends much of his time researching Internal medicine, Androgen receptor, Pharmacology, Endocrinology and Prostate cancer.
In his research on the topic of Internal medicine, Tumor lysis syndrome and Chronic lymphocytic leukemia is strongly related with Oncology.
James T. Dalton is studying Selective androgen receptor modulator, which is a component of Androgen receptor.
His Pharmacology research incorporates themes from Metabolite, Cancer and In vivo.
In the field of Endocrinology, his study on Testosterone, Osteopenia and Estrogen overlaps with subjects such as Lean body mass.
His research investigates the connection with Prostate cancer and areas like Cancer research which intersect with concerns in LNCaP, Breast cancer and Cytotoxicity.
He most often published in these fields:
- Internal medicine (37.78%)
- Androgen receptor (34.01%)
- Pharmacology (31.74%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer research (15.62%)
- Androgen receptor (34.01%)
- Internal medicine (37.78%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Androgen receptor, Internal medicine, Prostate cancer and Breast cancer.
His Androgen receptor study incorporates themes from Bioinformatics, Halogen, Receptor, Clinical endpoint and Pharmacology.
His work carried out in the field of Pharmacology brings together such families of science as Fibrosis and Obesity.
The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine.
His Prostate cancer research is multidisciplinary, relying on both Tubulin, Amyotrophic lateral sclerosis, Paclitaxel and Urology.
His studies in Breast cancer integrate themes in fields like AR Positive and Selective androgen receptor modulator.
Between 2013 and 2021, his most popular works were:
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma (363 citations)
- Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials) (79 citations)
- TMPRSS2:ERG Gene Fusion Predicts Subsequent Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia (79 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Androgen receptor, Internal medicine, Cancer research, Cancer and Receptor.
His Androgen receptor study results in a more complete grasp of Prostate cancer.
His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology.
His Endocrinology study combines topics in areas such as Steroid hormone receptor and Amyotrophic lateral sclerosis.
His studies examine the connections between Cancer research and genetics, as well as such issues in Androgen, with regards to Agonist, Antagonist, Aromatase and Indazole.
He has researched Cancer in several fields, including Osteosarcoma, Somatic cell, Pharmacology and Mechanism of action.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
